| Literature DB >> 35205105 |
Edward J Collins1,2, Cressida Bowyer2, Audrey Tsouza1, Mridula Chopra1.
Abstract
This review outlines the health benefits associated with the regular consumption of tomatoes and tomato products. The first section provides a detailed account of the horticultural techniques that can impact the quality of the fruit and its nutritional properties, including water availability, light intensity, temperature, and growing media. The next section provides information on the components of tomato that are likely to contribute to its health effects. The review then details some of the health benefits associated with tomato consumption, including anticancer properties, cardiovascular and neurodegenerative diseases and skin health. This review also discusses the impact tomatoes can have on the gut microbiome and associated health benefits, including reducing the risk of inflammatory bowel diseases. Other health benefits of eating tomatoes are also discussed in relation to effects on diabetes, the immune response, exercise recovery, and fertility. Finally, this review also addresses the negative effects that can occur as a result of overconsumption of tomato products and lycopene supplements.Entities:
Keywords: cardiovascular; diabetes; exercise; fertility; horticulture; lycopene; microbiome; neurodegenerative; skin health; tomato; vitamin C
Year: 2022 PMID: 35205105 PMCID: PMC8869745 DOI: 10.3390/biology11020239
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Figure 1Infographic representing the nutrients obtained from an average round tomato and how these relate to the daily recommended intakes [68,69].
(a) Carotenoids and glycoalkaloids found in tomato ripe fruits. (b) Vitamins and polyphenols found in tomato ripe fruits.
|
|
|
| |||
| Carotenoids (tetraterpenoids) | Carotenes | α-Carotene [ | Cardiovascular [ | ||
| β-Carotene [ | Cardiovascular [ | ||||
| Lycopene [ | Cancer [ | ||||
| Neurosporene [ | Skin [ | ||||
| Phytoene [ | Skin [ | ||||
| Phytofluene [ | Skin [ | ||||
| Glycoalkaloids | Saponins | Tomatine [ | Cancer [ | ||
| Esculeoside A [ | Diabetes [ | ||||
| Lycoperoside H [ | Skin [ | ||||
|
| |||||
| Polyphenols | Flavonoids | Kaempferol [ | Quercetin [ | Naringenin [ | Diabetes [ |
| Phenolic acids | Caffeic acid [ | p-Coumaric acid [ | Ferulic acid [ | Cancer [ | |
| Stillbenoids | Resveratrol [ | Cancer [ | |||
| Anthocyanins | Delphinidin [ | Petunidin [ | Cancer [ | ||
| Vitamins | B | Folate (vitamin B9) [ | Infertility [ | ||
| C | Ascorbic acid [ | Cancer [ | |||
| E | α-Tocopherol [ | Cancer [ | |||
| K | Phylloquinone (vitamin K1) [ | Atherosclerosis [ | |||
Main findings of the effect of tomato compounds on cancers.
| Biological Property | Type of Study | Main Findings | References |
|---|---|---|---|
| Antioxidant and anticancer activity | In vitro study with human prostate cancer (PC-3) and human breast adenocarcinoma (MCF-7) cell lines. | Cell viability assay showed chemically induced lycopene oxidised products (1–50 µM) were a key component in cancer cell apoptosis. | [ |
| In vitro study with HL-60 human promyelocytic leukaemia cells. | Products of lycopene oxidation, identified by spectral analyses, were added to HL-60 cell suspension as a 1% ( | [ | |
| Anti-angiogenic role in cancer cells | In vitro study testing human umbilical vein endothelial cells (HUVEC) and rat aortic rings. | Lycopene inhibited angiogenesis in HUVEC and rat aortic rings at physiologically relevant concentrations (1–2 μmol/L) when angiogenesis was analysed using phase-contrast microscopy. | [ |
| In vitro and in vivo study testing human umbilical vein endothelial cells (HUVEC). | Lycopene (0, 1, 5, 10 µM) was shown to inhibit angiogenesis of HUVEC cells in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K–Akt and ERK/p38 signalling pathways. Cell proliferation assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, cell migration assessed with Millipore QCM™ Endothelial Migration Assay Kit. | [ | |
| Longitudinal cohort study. | Lycopene used as a marker of tomato intake and higher intake inversely correlated with total, and the aggressive nature of prostate cancer. The reduced severity of cancer and lesser degree of angiogenesis were reported only in individuals who consumed a tomato-rich diet for a long time period but not in those whose intake recently increased. Tissue microarrays and immunohistochemistry were used to assess tumour biomarker expression. | [ | |
| Modulation of molecular pathways in cancer cells | In vitro study with HT-29 human colon cancer cells. | Lycopene treatment (0, 2, 5, 10 µM) was shown to inhibit the PI3K–AKT signalling pathway in colon cancer cells, demonstrating its effects on tumour development via angiogenesis inhibition. Assessment of cell proliferation using MTT assay and gene expression investigated using transient transfection and luciferase reporter assays. | [ |
| Ex vivo and in vivo study testing human umbilical vein endothelial cells (HUVEC) and rat aortic rings. | Lycopene (400 μg/mouse) reduced angiogenesis cell signalling through inhibition of the VEGF cell signalling pathway. Anti-angiogenic activity of lycopene confirmed by ex vivo rat aortic ring and in vivo chorioallantoic membrane assays. | [ | |
| In vitro study with human prostate (PC-3) and breast (MDA-MB-231) cancer cell lines. | Lycopene (0.5–5 µM) inhibited different stages of the NF-κB cell signalling pathway in both cancer cell lines in vitro as seen in Western blots and NF-κB-responsive gene activation reporter assays. | [ | |
| In vitro study in human gastric cancer (AGS) cells. | Lycopene at 0.3% was shown to induce apoptosis by inhibiting Wnt/β-catenin signalling, stopping the nuclear translocation of β-catenin and suppressing the expression of specific cell survival genes AGS cells. Cell viability, DNA fragmentation, and ROS concentrations were examined in these cells. | [ | |
| Cytotoxicity and cancer cell growth | In vitro study testing human prostate epithelial cells (PrEC). | PrEC treated with lycopene (up to 5 μmol/L) showed no expression of cyclin D1 in vitro. This regulatory subunit of kinases essential to the cancer cell cycle, resulting in reduced cancer cell cycle progression. High-performance liquid chromatography (HPLC) analysis, a thymidine incorporation assay, and flow cytometry were carried out to assess the impact of lycopene. | [ |
| In vitro study testing human prostate (PC-3) and breast (MDA-MB-231) cancer cell lines. | PC-3 and MDA-MB-231 cancer cell lines were tested in vitro in the absence and presence of lycopene at concentrations of 0.5–5 µM. MTS cell growth assays, Western blots, and NF-κB-responsive gene activation reporter assays showed that lycopene inhibits the NF-kB pathway at different stages in both cell lines. | [ | |
| In vitro study treating Caco-2 colon cancer cells. | Treatment of Caco-2 colon cancer cells with 150 μmol/L dietary fibre ferulic acid delayed cell cycle progression in the S phase. Gene expression was analysed with cDNA microarray technique. | [ | |
| Cancer cell apoptosis | In vitro study testing human prostate cells (PC-3). | Flow cytometry analysis showed 27–32% apoptosis in PC-3 when supplemented with (10–50 μM) β-carotene. | [ |
| Gap junction communication in cancer cells | In vitro study with rat liver epithelial WB-F344 cells. | Incubation of WB-F344 cells with oxidation products of lycopene (0.2% | [ |
Main findings of the effects of tomatoes on conditions detailed as part of this review.
| Condition | Study Type | Main Findings | References |
|---|---|---|---|
| Hypertension | Double-blind placebo study of grade 1 hypertension patients. | Subjects were administered one Lyc-O-Mato tablet (250 mg capsule consists of 15 mg lycopene (6%), beta carotene (0.15%), phytoene, and phytofluene (1%); and 5 mg vitamin E (2%), phospholipids (15%), and phytosterol (0.6%), suspended in tomato oleoresin oil) per day over an 8-week treatment period. Systolic and diastolic blood pressure was found to decrease following this short-term treatment. | [ |
| Atherosclerosis | Randomised, double-blinded, placebo-controlled cross-over study with 90 human subjects selected for normal platelet function. Ex vivo platelet aggregation induced by ADP and collagen were measured. | Study suggested administration of a standardised tomato extract drink (200 mL per day) may have a role in atherosclerosis prevention by reducing platelet activation 3 h after consumption. Significant reductions in ex vivo platelet aggregation were observed 3 h after tomato extract drink consumption. | [ |
| Inflammation | Open, prospective, randomised, cross-over, controlled feeding trial. | Participants received either 7 g of raw tomato, 3.5 g of tomato sauce, or 3.5 g of tomato sauce with refined olive oil and 0.25 g of sugar dissolved in water (each per kg of body weight) on four different days with a month interval between each.The day of intervention, blood samples were collected in ethylenediaminetetraacetic acid (EDTA) tubes at baseline (0 h) and 6 h after the supplementation. Results of blood parameter analysis suggested that reduced inflammation was due to decreased LDL-cholesterol levels after tomato supplementation. | [ |
| Atopic dermatitis | In vitro study. | Atopic dermatitis is linked to an overproduction of ROS and a decrease in antioxidant defence, as seen in skin biopsy specimens treated with thymodressin (0.1%, 1 mL over 30 days). Tomatoes are a natural source of antioxidants that protect skin cells against ROS. | [ |
| Liver inflammatory disease | In vivo study with 49 mice. | Mice supplemented with tomato powder (238.8 mg of lycopene, 10.9 mg of β-carotene, and a trace amount of phytoene per 100 g) in the amount 41.9 g/kg diet. Tomato powder was shown to have a significant increase in microbiome diversity and richness, leading to a reduced production of hepatotoxic compounds such as lipopolysaccharides. | [ |
| Neurodegenerative disorders | In vitro study testing human neuroblastoma SH-SY5Y cells. | Cells treated with lycopene (0.2 or 0.5 µM) were monitored for ROS levels, apoptosis, NF-κB activation and Nucling expression, cell viability, mitochondrial membrane potential, and oxygen consumption rate. Lycopene treatment reduced apoptosis by decreasing ROS and inhibited mitochondrial dysfunction and NF-κB target gene Nucling expression in cells. | [ |
| Diabetes | In vivo study with 16 mice. | Esculeoside A (main saponin compound in tomatoes) was administered to the mice for 56 days (100 mg/kg). Examination of blood and liver biochemical parameters and liver insulin signalling-related protein expression showed that esculeoside A reduced fasting blood glucose levels and improved glucose tolerance, suggesting it can be a functional supplement for diabetes treatment. | [ |
| Exercise-induced physiological stress | Randomised control trial on 15 anaerobically trained athletes of similar age and BMI. | Biochemical evaluation suggested that athlete’s replacement of “usual carbohydrate supplementation beverage” with 100 g tomato juice led to a significant decrease in compounds LDH and CPK related to muscle damage due to anaerobic exercise. | [ |
| Pathogenic infection | Blinded, randomised, cross-over study. | Enhanced lytic activity of natural killer cells and lymphocyte proliferation observed in human subjects supplemented with 330 mL/day tomato or carrot juice (both high in β-carotene). | [ |
| OS and infertility | Randomised experimental study on male infertility patients with poor sperm concentration. | OS, caused by a build-up of ROS, is a main mediator of female infertility. Antioxidants found in tomatoes reduce cellular ROS content. Daily consumption of “one can” of tomato juice (containing 30 g lycopene) was shown to improve sperm motility after seminal parameters were measured every 6 weeks during tomato juice consumption period. | [ |